Researcher charged with illegal trades of Peninsula cancer drug maker's stock

The gastric cancer trial results were key to the company's $1.9 billion acquisition earlier this year by Amgen Inc.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 21, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news